In recent years, the increase in the frequency of gonorrhoea has reached alarming levels in many countries (Hart, 1971; Guthe, 1971; Juhlin, 1971; Delune, 1971; Gay-Prieto, 1971) . Some believe that gonorrhoea is now 'out of control' mainly because of non-medical factors (Guthe, 1971; Baccareda-Boy and Rebora, 1971; Sparling and McKenzie-Pollock, 1971) . Although Neisseria gonorrhoeae is susceptible to various drugs, there is still a need for new drugs that would approach the ideal as closely as possible, i.e. to be highly effective in a single-dose in uncomplicated cases.
Spectinomycin (formerly actinospectacin) is a broad-spectrum antibiotic derived from Streptomyces spectabilis (Hanka, Mason, and Sokolski, 1961; Mason, Dietz, and Smith, 1961; Holloway and Scott, 1963) . The sulphate was found to be effective in urogenital infections, especially gonorrhoea (Mason and others, 1961; Lindemeyer, Turck, and Petersdorf, 1962; Holloway and Scott, 1963; Vineyard, Mays, and Sanford, 1963) . Recently the more soluble hydrochloride derivative has been used to treat gonorrhoea with good results (Platts, 1970; Labowitz, Porter, and Holloway, 1970; Savage, 1971) . Cornelius and Domescik (1970) (Barry and Koch, 1963; Romansky, Walters, Johnson, and Peck, 1962) .
Patients and methods
Spectinomycin hydrochloride was given to seventy male patients aged between 17 and 48 years who were suffering from acute gonorrhoea. The symptoms varied in duration from 24 hours to 4 days. The disease was diagnosed by both smear and culture.
The drug was given in a single dose of 2 g. intramuscularly. Results were assessed clinically and bacteriologically after 24 hours and again after 8 days.
Five out of the original seventy patients defaulted and our results are based on the remaining 65 patients.
Findings
Gonococci were isolated in all seventy patients before treatment and all strains were inhibited in vitro by discs of 30 Fg. spectinomycin (Table I) . Marked improvement in symptoms occurred in all except one patient within a few hours of the injection. Clinical examination 24 hours later revealed only a slight mucous secretion and appearances were normal after 8 days. Table II shows that only one of the 65 patients who attended for follow-up continued to harbour the gonococcus. No side-effects were observed except for slight pain at the site of injection. 
